Good point but the thrust of the oncosil treatment is to show an additive effect and while it remains to be proven, it is likely that local radiotherapy will augment the effect of whatever is the most advanced in drug treatment.
- Forums
- ASX - By Stock
- OSL
- Ann: Positive Overall Survival data released at ASCO 2019 Chicago
OSL
oncosil medical ltd
Add to My Watchlist
2.00%
!
$1.02

Ann: Positive Overall Survival data released at ASCO 2019 Chicago, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 192 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 192 | 1.025 |
1 | 550 | 1.020 |
1 | 2993 | 1.000 |
1 | 3000 | 0.990 |
1 | 1000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.040 | 6234 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.190 | 3563 | 1 |
Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online